27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Gainers
- Sol-Gel Technologies, Inc. (NASDAQ:SLGL) shares moved upwards by 154.6% to $23.50 during Monday's pre-market session.
- Savara, Inc. (NASDAQ:SVRA) stock rose 40.5% to $2.43.
- KemPharm, Inc. (NASDAQ:KMPH) shares increased by 18.8% to $0.50. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.
- Cassava Sciences, Inc. (NASDAQ:SAVA) stock moved upwards by 18.0% to $6.15.
- Capricor Therapeutics, Inc. (NASDAQ:CAPR) stock rose 12.0% to $1.31.
- Guardion Health Sciences, Inc. (NASDAQ:GHSI) shares surged 9.5% to $0.23.
- InVivo Therapeutics Hldg, Inc. (NASDAQ:NVIV) shares increased by 8.9% to $0.20.
- Onconova Therapeutics, Inc. (NASDAQ:ONTX) shares moved upwards by 8.7% to $0.45.
- Myriad Genetics, Inc. (NASDAQ:MYGN) shares increased by 8.3% to $29.00.
- Genprex, Inc. (NASDAQ:GNPX) shares rose 8.1% to $0.29.
- Brickell Biotech, Inc. (NASDAQ:BBI) shares increased by 7.1% to $1.65.
- Avita Medical, Inc. (NASDAQ:RCEL) shares moved upwards by 5.8% to $9.45.
- Check-Cap, Inc. (NASDAQ:CHEK) stock moved upwards by 5.7% to $1.85.
- Bionano Genomics, Inc. (NASDAQ:BNGO) stock moved upwards by 4.6% to $1.13.
- Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares surged 4.5% to $0.18. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
- Advaxis, Inc. (NASDAQ:ADXS) shares increased by 4.3% to $0.85.
- Spring Bank, Inc. (NASDAQ:SBPH) stock increased by 3.6% to $1.31. The most recent rating by B. Riley FBR, on December 30, is at Neutral, with a price target of $2.00.
- Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stock surged 3.5% to $2.35. The most recent rating by Oppenheimer, on December 20, is at Outperform, with a price target of $6.00.
- Solid Biosciences, Inc. (NASDAQ:SLDB) stock moved upwards by 3.5% to $4.43. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.
- Ocugen, Inc. (NASDAQ:OCGN) stock surged 3.5% to $0.41. According to the most recent rating by H.C. Wainwright, on December 20, the current rating is at Buy.
- Viveve Medical, Inc. (NASDAQ:VIVE) stock moved upwards by 3.4% to $0.93. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
- Durect, Inc. (NASDAQ:DRRX) stock increased by 3.4% to $3.37. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.
- Axsome Therapeutics, Inc. (NASDAQ:AXSM) shares moved upwards by 3.2% to $105.21. The most recent rating by Guggenheim, on December 16, is at Buy, with a price target of $158.00.
- Achieve Life Sciences, Inc. (NASDAQ:ACHV) shares moved upwards by 2.8% to $0.55.
- Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares rose 2.3% to $3.62. The most recent rating by B. Riley FBR, on December 27, is at Buy, with a price target of $11.00.
Losers
- WAVE Life Sciences, Inc. (NASDAQ:WVE) shares decreased by 32.6% to $10.65 during Monday's pre-market session. The most recent rating by SunTrust Robinson Humphrey, on December 17, is at Buy, with a price target of $27.00.
- ContraFect, Inc. (NASDAQ:CFRX) stock fell 7.2% to $0.61.
- NewLink Genetics, Inc. (NASDAQ:NLNK) stock decreased by 6.1% to $2.60.
- Iterum Therapeutics, Inc. (NASDAQ:ITRM) stock fell 5.0% to $4.51. The most recent rating by RBC Capital, on December 11, is at Outperform, with a price target of $10.00.
- Mereo BioPharma Group, Inc. (NASDAQ:MREO) shares declined 3.4% to $2.85.
- vTv Therapeutics, Inc. (NASDAQ:VTVT) shares decreased by 3.4% to $1.73.
- Rite Aid, Inc. (NYSE:RAD) shares declined 3.0% to $19.65.
- Assertio Therapeutics, Inc. (NASDAQ:ASRT) shares plummeted 2.9% to $1.35.
- Agile Therapeutics, Inc. (NASDAQ:AGRX) shares decreased by 2.9% to $2.36.
- Proteostasis Therapeutics, Inc. (NASDAQ:PTI) shares fell 2.7% to $2.17.
- Aurora Cannabis, Inc. (NYSE:ACB) shares declined 1.8% to $1.88. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.
- Fresenius Medical Care, Inc. (NYSE:FMS) shares decreased by 1.6% to $36.81. According to the most recent rating by Redburn, on October 23, the current rating is at Neutral.
- Biocept, Inc. (NASDAQ:BIOC) stock plummeted 1.4% to $0.25.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!